Karur Vysya Bank Regulatory Approval

Karur Vysya Bank Promoter Selling: ₹0.05 Cr

Promoter group member M V Usha sold 1,500 shares via market sale on 29 October 2026 worth Rs.5.35 lakh. Her stake stayed near 0.03%.

Value

₹0.05 Cr

Karur Vysya Bank Capacity Expansion

Karur Vysya Bank will inaugurate eight new branches on October 30, 2026, across several states. No financial amount is disclosed, so the filing reports branch expansion only.

new branches

8.0 branches

Karur Vysya Bank Promoter Buying (Off-Market)

Karur Vysya Bank promoters executed an inter-se transfer of 3,00,000 shares within the promoter group on 23 October 2026. Net promoter group holding is unchanged, and no consideration was disclosed.

Promoter stake change

+0.02%

Karur Vysya Bank Promoter Selling: ₹0.93 Cr

Promoter A J Suriyanarayana sold 25,000 Karur Vysya Bank shares on the market on 19 October 2026. The trade was valued at Rs.0.93 Crore.

Value

₹0.93 Cr

Karur Vysya Bank Promoter Selling: ₹0.23 Cr

Promoters and promoter group members of Karur Vysya Bank sold a total of 6,000 equity shares through open market transactions.

Value

₹0.23 Cr

Karur Vysya Bank Promoter Selling: ₹0.07 Cr

Promoter and Promoter Group members sold 2,000 equity shares of Karur Vysya Bank Ltd in the open market.

Value

₹0.07 Cr

John Cockerill India Regulatory Approval

John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.

Gland Pharma Regulatory Approval

Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.

City Union Bank Regulatory Approval

City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.

Execution

Three years from the date of taking charge

Lupin Regulatory Approval

Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.

Som Distilleries & Breweries Regulatory Approval

Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.

AGI Infra Regulatory Approval

Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.

Execution

Valid up to March 30, 2031